George Yancopoulos, EVP CSO President Regeneron Re at REGENERON PHARMACEUTICALS INC (REGN), sold 33,165 shares at $133.95 ($4.5M) on 2012-05-01, disclosed to the SEC on 2012-05-02.
Scheduled sale ($4.5M) by EVP CSO President Regeneron Re under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $133.95 | 100 | $13K | 0.3% |
| 2 | $134.54 | 20,120 | $2.7M | 60.5% |
| 3 | $135.29 | 12,945 | $1.8M | 39.2% |
| Total | $134.83 avg | 33,165 | $4.5M | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |